RxDoctor Payments Data

Andrea Kremsreiter, PA

Physician Assistant · Solvang, CANPI 1164880811

Payments from drug & device makers

$1,681in general payments, 2019–2025

Across 28 payments — averaging $60.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Merck$256
  • Gilead$114
  • Tolmar Pharmaceuticals, Inc.$56
  • GSK$30
  • Seagen Inc.$26
  • plus $101 from 5 others

What the payments were for

  • Food & beverage$52831%
  • Education$563%
  • Other$1,09765%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,681 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$90,256
Medicare patients
380
Services billed
970

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbrancePalbociclib15$239,410
BosulifBosutinib19$230,920
BrukinsaZanubrutinib12$181,150
VenclextaVenetoclax13$178,272
Imatinib Mesylate19$75,857
XareltoRivaroxaban14$17,227
EliquisApixaban19$12,740
Abiraterone Acetate19$10,492
Anastrozole66$1,314
Hydroxyurea39$639
Prednisone55$431
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine13$343
Acyclovir14$220
Ondansetron Hcl14$178
Tamoxifen Citrate12$153

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerIbrance, Bosulif, Eliquis$15$483,06953 claims
Johnson & JohnsonXarelto$23$17,22714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Solvang

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →